Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies
Author:
Affiliation:
1. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
2. Eli Lilly and Company, Indianapolis, IN
3. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC
Funder
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Publisher
Informa UK Limited
Subject
Statistics, Probability and Uncertainty,Statistics and Probability
Link
https://www.tandfonline.com/doi/pdf/10.1080/01621459.2017.1303386
Reference38 articles.
1. Standards of Medical Care in Diabetes—2014
2. DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results
3. Analysis of randomized comparative clinical trial data for personalized treatment selections
4. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Artificial intelligence for diabetes care: current and future prospects;The Lancet Diabetes & Endocrinology;2024-08
2. Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data;Statistics in Medicine;2024-07-25
3. Estimating Individualized Treatment Regimes to Optimize Incremental Cost-Effectiveness Ratio;Statistics in Biosciences;2024-07-04
4. Risk-aware restricted outcome learning for individualized treatment regimes of schizophrenia;The Annals of Applied Statistics;2024-06-01
5. Partisan Panel Composition and Reliance on Earlier Opinions in the Circuit Courts;Journal of Law and Empirical Analysis;2024-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3